Xixi Wu
Papers
1
Total Citations
30
H-Index
1
About
Xixi Wu is a clinical researcher specializing in rehabilitation robotics and neurorehabilitation, with a particular focus on improving locomotor outcomes for stroke survivors. Wu's most notable contribution is a rigorous multi-center, randomized controlled trial evaluating the BEAR-H1 lower-limb exoskeletal robot — a novel device developed by Shenzhen Milebot Robot Technology — for restoring walking function in subacute stroke patients. This landmark study, published in 2021 and accumulating 30 citations, employed a non-inferiority design to rigorously compare robotic-assisted therapy against conventional rehabilitation approaches, reflecting Wu's commitment to evidence-based standards in an emerging field. Conducted in collaboration with the First Affiliated Hospital of Nanjing and multiple partner institutions, the work underscores Wu's capacity to lead complex, large-scale clinical investigations. By bridging cutting-edge robotic engineering with clinical rehabilitation science, Wu's research contributes meaningfully to establishing the safety and therapeutic validity of wearable exoskeletal systems. This work is particularly significant for clinicians and engineers seeking translatable evidence to support the integration of assistive robotics into mainstream stroke recovery programs.
Research Focus
Key Achievements
Top Papers
- 1